Aptose Biosciences Stock Working Capital
| APS Stock | CAD 5.10 0.56 9.89% |
Aptose Biosciences fundamentals help investors to digest information that contributes to Aptose Biosciences' financial success or failures. It also enables traders to predict the movement of Aptose Stock. The fundamental analysis module provides a way to measure Aptose Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aptose Biosciences stock.
Aptose |
Aptose Biosciences Company Working Capital Analysis
Aptose Biosciences' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Aptose Biosciences Working Capital | (3.38 M) |
Most of Aptose Biosciences' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aptose Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Aptose Biosciences has a Working Capital of (3.38 Million). This is 100.79% lower than that of the Biotechnology sector and 100.63% lower than that of the Health Care industry. The working capital for all Canada stocks is 100.23% higher than that of the company.
Aptose Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptose Biosciences' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptose Biosciences could also be used in its relative valuation, which is a method of valuing Aptose Biosciences by comparing valuation metrics of similar companies.Aptose Biosciences is currently under evaluation in working capital category among its peers.
Aptose Fundamentals
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.42 | ||||
| Current Valuation | 745.22 K | ||||
| Shares Outstanding | 2.14 M | ||||
| Shares Owned By Insiders | 5.71 % | ||||
| Shares Owned By Institutions | 7.79 % | ||||
| Number Of Shares Shorted | 23.55 K | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 68.22 X | ||||
| EBITDA | (52.27 M) | ||||
| Net Income | (51.21 M) | ||||
| Cash And Equivalents | 36.37 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 1.01 M | ||||
| Debt To Equity | 5.00 % | ||||
| Current Ratio | 11.27 X | ||||
| Book Value Per Share | (14.04) X | ||||
| Cash Flow From Operations | (44.59 M) | ||||
| Short Ratio | 7.22 X | ||||
| Earnings Per Share | (125.24) X | ||||
| Target Price | 31.02 | ||||
| Number Of Employees | 35 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 12.13 M | ||||
| Total Asset | 12.99 M | ||||
| Retained Earnings | (515.54 M) | ||||
| Working Capital | (3.38 M) | ||||
| Net Asset | 12.99 M |
About Aptose Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptose Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptose Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptose Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.